India's Biotech Sector: A $10B to $195B Quantum Leap

India's biotech sector growth has reached a major milestone. Specifically, the industry expanded from $10 billion to over $195 billion within a single decade. Union Minister Dr. Jitendra Singh announced this leap at BIRAC’s 14th Foundation Day. This rapid expansion reflects a robust 18% annual growth rate. Consequently, the sector now contributes approximately 4.8% to the national GDP.

Factors Fueling India's Biotech Sector Growth

Several factors have catalyzed this massive expansion since 2014. Firstly, the government established an enabling policy environment that prioritizes science and technology. Additionally, BIRAC has emerged as a critical interface between public and private sectors. It facilitates targeted funding, mentorship, and industry-academia partnerships. Consequently, the number of biotech startups in India has skyrocketed from just 50 to over 11,800 today.

Moreover, the launch of the BioE3 Policy marks a significant strategic shift. This policy focuses on economy, environment, and employment by promoting sustainable biomanufacturing. For instance, the government is setting up biofoundries and Bio-AI hubs to support deep-tech innovation. Therefore, these initiatives ensure that India remains a global leader in precision medicine and biopharmaceuticals.

Future Prospects and Strategic Goals

India is now on a clear path to becoming the world’s third-largest economy. The country aims to reach a $300 billion bioeconomy by 2030. To achieve this, the government is utilizing a ₹1 lakh crore Research, Development, and Innovation (RDI) Fund. This fund supports high-risk scientific innovation and clinical research. Although challenges like the COVID-19 pandemic existed, the sector demonstrated remarkable resilience. Specifically, the biopharma segment remains the largest contributor, accounting for 35% of the total bioeconomy value.

Frequently Asked Questions

Q1: What is the current value of India's bioeconomy?

As of March 2026, India's bioeconomy is valued at approximately $195.3 billion, having grown from $10 billion in 2014.

Q2: What is the role of BIRAC in this growth?

BIRAC acts as a model institution that bridges the gap between academia and industry. It provides risk capital, infrastructure support, and mentorship to over 11,000 startups.

Q3: What is the target for India's biotech sector by 2030?

The Indian government has set an ambitious target to reach a $300 billion bioeconomy by the year 2030.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. India’s biotech sector grows from $10 billion to over $195 billion in a decade:Jitendra Singh - ETHealthworld


2. India’s Bioeconomy surges from $10 billion to $195 billion in a decade, Registers 17–18% Annual Growth: Dr Jitendra Singh - PIB (2026)


3. India’s Bioeconomy Reaches $195 Billion Milestone - The Policy Edge (2026)